These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

912 related items for PubMed ID: 16909000

  • 1. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A, Zetterberg H, Håkansson A, Nissbrandt H, Blennow K.
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [Abstract] [Full Text] [Related]

  • 2. Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease.
    Conrad C, Vianna C, Schultz C, Thal DR, Ghebremedhin E, Lenz J, Braak H, Davies P.
    J Neurochem; 2004 Apr; 89(1):179-88. PubMed ID: 15030402
    [Abstract] [Full Text] [Related]

  • 3. Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.
    Rosso SM, van Herpen E, Pijnenburg YA, Schoonenboom NS, Scheltens P, Heutink P, van Swieten JC.
    Arch Neurol; 2003 Sep; 60(9):1209-13. PubMed ID: 12975285
    [Abstract] [Full Text] [Related]

  • 4. Strong association between Saitohin gene polymorphism and tau haplotype in the Polish population.
    Pepłońska B, Zekanowski C, Religa D, Czyzewski K, Styczyńska M, Pfeffer A, Gabryelewicz T, Gołebiowski M, Luczywek E, Wasiak B, Barczak A, Chodakowska M, Barcikowska M, Kuźnicki J.
    Neurosci Lett; 2003 Sep 18; 348(3):163-6. PubMed ID: 12932819
    [Abstract] [Full Text] [Related]

  • 5. High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal β-amyloid in Parkinson disease.
    Compta Y, Ezquerra M, Muñoz E, Tolosa E, Valldeoriola F, Rios J, Cámara A, Fernández M, Buongiorno MT, Marti MJ.
    Neurosci Lett; 2011 Jan 07; 487(2):169-73. PubMed ID: 20951764
    [Abstract] [Full Text] [Related]

  • 6. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
    Wang B, Zhou S, Yang Z, Xie YC, Wang J, Zhang P, Lv Z, Zheng C, Ma X.
    J Neurol Sci; 2008 Jul 15; 270(1-2):148-51. PubMed ID: 18396294
    [Abstract] [Full Text] [Related]

  • 7. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M, Ramasamy K, Russ C, Freeman SH, Orne J, Raju S, Matsui T, Growdon JH, Frosch MP, Ghetti B, Brown RH, Irizarry MC, Hyman BT.
    Acta Neuropathol; 2007 Nov 15; 114(5):471-9. PubMed ID: 17721707
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.
    Johansson A, Zetterberg H, Hampel H, Buerger K, Prince JA, Minthon L, Wahlund LO, Blennow K.
    Dement Geriatr Cogn Disord; 2005 Nov 15; 20(6):367-74. PubMed ID: 16192727
    [Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
    Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P.
    Biol Psychiatry; 2008 Nov 15; 64(10):850-5. PubMed ID: 18395699
    [Abstract] [Full Text] [Related]

  • 11. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).
    Koopman K, Le Bastard N, Martin JJ, Nagels G, De Deyn PP, Engelborghs S.
    Neurochem Int; 2009 Sep 15; 55(4):214-8. PubMed ID: 19524111
    [Abstract] [Full Text] [Related]

  • 12. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
    Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM.
    Am J Pathol; 1994 Dec 15; 145(6):1472-84. PubMed ID: 7992850
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.
    Grossman M, Farmer J, Leight S, Work M, Moore P, Van Deerlin V, Pratico D, Clark CM, Coslett HB, Chatterjee A, Gee J, Trojanowski JQ, Lee VM.
    Ann Neurol; 2005 May 15; 57(5):721-9. PubMed ID: 15852395
    [Abstract] [Full Text] [Related]

  • 14. Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease.
    Ezquerra M, Campdelacreu J, Gaig C, Compta Y, Muñoz E, Martí MJ, Valldeoriola F, Tolosa E.
    Neurosci Lett; 2008 Dec 19; 448(1):20-3. PubMed ID: 18930114
    [Abstract] [Full Text] [Related]

  • 15. A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain.
    Green EK, Thaker U, McDonagh AM, Iwatsubo T, Lambert JC, Chartier-Harlin MC, Harris JM, Pickering-Brown SM, Lendon CL, Mann DM.
    Neurosci Lett; 2002 May 17; 324(2):113-6. PubMed ID: 11988340
    [Abstract] [Full Text] [Related]

  • 16. The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.
    Sjölander A, Minthon L, Bogdanovic N, Wallin A, Zetterberg H, Blennow K.
    Neurobiol Aging; 2009 Apr 17; 30(4):666-8. PubMed ID: 17850927
    [Abstract] [Full Text] [Related]

  • 17. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S.
    J Med Assoc Thai; 2011 Feb 17; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [Abstract] [Full Text] [Related]

  • 18. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.
    Arch Neurol; 2009 Mar 17; 66(3):382-9. PubMed ID: 19273758
    [Abstract] [Full Text] [Related]

  • 19. Association of GSK3B with Alzheimer disease and frontotemporal dementia.
    Schaffer BA, Bertram L, Miller BL, Mullin K, Weintraub S, Johnson N, Bigio EH, Mesulam M, Wiedau-Pazos M, Jackson GR, Cummings JL, Cantor RM, Levey AI, Tanzi RE, Geschwind DH.
    Arch Neurol; 2008 Oct 17; 65(10):1368-74. PubMed ID: 18852354
    [Abstract] [Full Text] [Related]

  • 20. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA, Charfeddine B, Lammouchi T, Harrabi I, Ben Othman L, Dridi H, Bennamou S, Limem K.
    Neurosci Lett; 2008 Aug 01; 440(2):145-9. PubMed ID: 18555606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.